1. Bone Morphogenetic Protein-6 Inhibits Fibrogenesis in Scleroderma Offering Treatment Options for Fibrotic Skin Disease
   Stephanie Arndt et al, 2019, Journal of Investigative Dermatology CrossRef
2. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis via regulation of TGF-β/Smad signaling pathway
   Gao-Liang Zou et al, 2019, World Journal of Gastroenterology CrossRef
3. Neuroimmunomodulation of adrenoblockers during liver cirrhosis: modulation of hepatic stellate cell activity
   Mariana Yazmin Medina Pizaño et al, 2023, Annals of Medicine CrossRef
4. Curcumin and α/β-Adrenergic Antagonists Cotreatment Reverse Liver Cirrhosis in Hamsters: Participation of Nrf-2 and NF-κB
   José Roberto Macías-Pérez et al, 2019, Journal of Immunology Research CrossRef
5. Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway
   Ai-Yuan Xiu et al, 2021, Drug Design, Development and Therapy CrossRef
6. rSjp40 inhibits activated hepatic stellate cells by promoting nuclear translocation of YB1 and inducing BMP-7/Smad1/5/8 pathway
   Liuting Chen et al, 2019, Parasites & Vectors CrossRef
7. Protective Effect of Curcumin against Doxazosin- and Carvedilol-Induced Oxidative Stress in HepG2 Cells
   Mariana Yazmin Medina-Pizaño et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
8. Doxazosin and Carvedilol Treatment Improves Hepatic Regeneration in a Hamster Model of Cirrhosis
   Sandra Alejandra Serna-Salas et al, 2018, BioMed Research International CrossRef